NewsHive
CONTACT USANALYST PORTAL →
cross-domainBACKGROUND

When AI drives discovery — Patents and drug development reut.rs/4vAzy1E

BACKGROUND
1 SIGNALFIRST DETECTED 16 July 2026
Narrative synthesis pending — 1 signal collected.
How the story developed
Other feeds and industry voices
21 Aug
AI drug discovery could force patent law to confront what it means to invent.

AI drug discovery could force patent law to confront what it means to invent.

OPINION · WHAT · MIT Technology ReviewOPEN STORY
23 Jul
AI shortens drug discovery to around 1 year in China, Insilico CEO says reut.rs/4wkXVSl

AI shortens drug discovery to around 1 year in China, Insilico CEO says reut.rs/4wkXVSl

OPINION · WHO · ReutersOPEN STORY
14 Apr
Amazon launches AI research tool to speed early-stage drug discovery reut.rs/4vA6p8g

Amazon launches AI research tool to speed early-stage drug discovery reut.rs/4vA6p8g

OPINION · WHAT · ReutersOPEN STORY
21 Aug
When AI designs a drug, who gets the credit?

When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the

REPORT · WHO · MIT Technology ReviewOPEN STORY
27 Jul
Closing the data loop in AI-driven drug discovery

Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of

REPORT · WHEN · MIT Technology ReviewOPEN STORY
30 Mar
Eli Lilly signs $2.75 billion AI drug deal with Insilico Medicine

<!-- SC_OFF --><div class="md"><p><a

OPINION · WHAT · ArtificialInteligenceOPEN STORY
Sources
Reuters

NewsHive monitors these sources continuously. All signal titles above link to the original reporting.

Intelligence by NewsHive. Need help navigating what this means for your business? Contact GeekyBee →